Introduction
Bcl-2 family proteins play a critical role in both the regulation and execution of apoptotic programmed cell death in numerous physiological contexts, and contribute in a fundamental way to several pathologies including cancer. The ability of the antiapoptotic members, when in excess, to provide protection against the inherent stress signals manifested by cancer cells as well as protecting these cells against many anticancer drugs has provided new opportunities for therapeutic interventions. Although our current understanding of the family has centered primarily on its control over mitochondrial integrity, emerging evidence is now arguing for an important contribution to the control of several pathways operating upstream of mitochondria, and emanating from the endoplasmic reticulum (ER). The concept that Bcl-2 regulates intracellular calcium homeostasis originated a decade ago (Baffy et al., 1993; Lam et al., 1994; Magnelli et al., 1994) . Interest in this concept has accelerated in recent years for three reasons. First, there is increasing recognition that calcium is involved in mediating apoptosis (see Orrenius et al., 2003; and Hajnoczky et al., 2003 for detailed reviews). Second, the major organelle involved in calcium homeostasis is the ER and there is increasing interest in the role of the ER in apoptosis (see Thomenius et al., 2003; and Breckenridge et al., 2003a for review) . Third, proapoptotic Bcl-2 family members have recently been found to have effects on calcium homeostasis in the ER (see Demaurex and Distelhorst, 2003 for review) . However, along with increased interest in the concept that Bcl-2 regulates calcium has come confusion and controversy due to conflicting evidence regarding the effect of Bcl-2 on ER luminal calcium. As discussed in this review, there are a number of reports indicating that Bcl-2 inhibits calcium release from the ER and preserves ER luminal calcium, whereas several recent reports have suggested that Bcl-2 increases the leakage of calcium across the ER membrane, thereby reducing luminal calcium. Interestingly, recent reviews have presented the latter viewpoint without mentioning the abundant evidence to the contrary (Demaurex and Distelhorst, 2003; Hajnoczky et al., 2003; Oakes et al., 2003; Orrenius et al., 2003; Rizzuto et al, 2003) . Therefore, the purpose of this review is to summarize the full scope of published findings regarding effects of Bcl-2 on ER calcium and to analyse the possible reasons why some reports indicate that Bcl-2 decreases ER luminal calcium but others do not (Table 1) .
Role of the ER in calcium homeostasis
Bcl-2 is located not only on mitochondria, but also on the endoplasmic reticulum (ER). The ER is a mutifunctional signaling organelle that controls a wide range of cellular processes. One of its primary functions is as a source of calcium signals that are released through inositol 1,4,5-trisphosphate (InsP 3 ) receptors or ryanodine receptors (for review see Putney et al., 2001; Petersen, 2002; Berridge et al., 2003) . Since work on Bcl-2 has mainly involved InsP 3 receptors, ryanodine receptors will be mentioned only briefly in this review. Many agonists that induce increases in cytosolic calcium do so by stimulating the production of InsP 3 at the plasma membrane. InsP 3 diffuses through the cytoplasm and binds with high affinity and specificity to InsP 3 receptors located in the ER membrane. These receptors are widely distributed and constitute a family of calcium channels with three main subtypes sharing similar but not identical functional properties (for review see Patel et al., 1999; Thrower et al., 2001) . InsP 3 receptors open transiently in response to InsP 3 , releasing calcium from the ER lumen into the cytoplasm. InsP 3 -induced calcium release produces rapid increases in cytosolic calcium concentration that form calcium spikes and waves. The frequency and amplitude of cytoplasmic calcium elevation transmits information that is sensed, for example, by calcium-sensitive phosphatases and kinases (for review see Putney et al., 2001; Petersen, 2002; Berridge et al., 2003) .
The calcium concentration within the ER lumen is very high compared to that of the surrounding cytoplasm. Maintenance of a high calcium concentration within the ER lumen is essential for a number of vital cellular processes including protein synthesis (Brostrom and Brostrom, 1990) , protein processing (Sambrook, 1990; Lodish et al., 1992) , cell division (Short et al., 1993) and calcium signal generation (Berridge, 1993) . The high luminal calcium concentration is maintained by SERCA pumps (sarcoplasmic endoplasmic reticulum calcium ATPase) located in the ER membrane maintain, as illustrated in the accompanying Figure 1 . These pumps counteract a leak of calcium from the ER into the surrounding cytoplasm. The nature of this calcium leak is poorly understood, but becomes evident when SERCA pumps are inhibited by thapsigargin (TG), a highly potent selective SERCA pump inhibitor (Thastrup et al., 1990) . When SERCA pumps are inhibited by TG calcium leaks down the steep concentration gradient from ER lumen into the surrounding cytoplasm, elevating cytoplasmic calcium concentration.
Calcium homeostasis in the ER is not only regulated by InsP 3 receptors and SERCA pumps, but also by luminal calcium-binding proteins, including calreticulin, GRP78 and GRP94. These proteins contribute to the retention of calcium within the ER lumen. A decrease in one or more of these proteins reduces luminal calcium content, whereas an increase in one or more of these proteins increases luminal calcium (Mery et al., 1996; Liu et al., 1997; Yu et al., 1999) . Thus, calcium homeostasis in the ER is a complex process that is regulated by multiple factors (for more detailed review see Berridge et al., 2003) .
Methods of measuring calcium
A number of tools are employed to measure and record dynamic changes in intracellular calcium concentration. The most commonly used is a calcium-sensitive fluorescent dye, Fura-2 AM. This dye is in the form of a cell permeant acetoxymethyl ester and therefore readily diffuses through the plasma membrane. Cytoplasmic esterases cleave the acetoxymethyl ester bonds, trapping the Fura-2 in the cytoplasm. Fura-2 fluroescence is measured either in a cell population by fluorometry, or on a single cell basis by digital imaging fluorescence microscopy. Another tool is TG (see above). Within seconds of adding TG to cells, SERCA pumps are inhibited and no longer able to maintain a steep concentration gradient of calcium across the ER membrane. As a consequence, calcium fluxes from the ER lumen into the cytoplasm, elevating cytoplasmic calcium concentration. The elevation of cytoplasmic calcium concentration induced by TG is an indirect measure of the total calcium within the ER lumen. However, it is not a precise measure, because the Figure 1 A number of regulators of ER calcium signaling have been identified that influence either calcium homeostasis or apoptosis outcomes, and could be targets of Bcl-2 function. The Bax-Bcl-2 setpoint, and its regulation by BH3-only proteins, is one example (Demeaurex and Distelhorst, 2003; Scorrano et al., 2003; Zhong et al., 2003) . Bap31, a component of the Bap31 complex at the ER, is a target of procaspase-8L following oncogenic E1A stimulation (Breckenridge et al., 2002) or of caspase-8a/b following Fas stimulation, yielding the proapoptotic p20 Bap31 fragment, which induces calcium-mediated mitochondrial fission and sensitization to direct apoptotic activation (Breckenridge et al., 2003b) . Other examples are SERCA pumps (Kuo et al., 1998; Vanden Abeele et al., 2002) , luminal calcium-binding proteins including GRP78, GRP94 and calreticulin (Vanden Abeele et al., 2002) and IP3 receptors (Li et al, 2002; Distelhorst and Roderick, 2003) cytoplasmic calcium elevation induced by TG can be affected by a number of other factors, including the activity of calcium pumps on the plasma membrane, mitochondrial calcium uptake, and cytoplasmic proteins that buffer the calcium elevation. With these caveats in mind, a number of laboratories have used TG to investigate potential effects of Bcl-2 on ER calcium. Only a few laboratories have attempted more direct measurement of ER luminal calcium concentration, as will be discussed later.
Evidence that Bcl-2 preserves ER calcium
The first observation suggesting that Bcl-2 regulates intracellular calcium homeostasis was published in 1992 (Baffy et al., 1992) . The studies were performed in an interleukin-3 (IL-3)-dependent hematopoietic cell line that undergoes apoptosis when IL-3 is withdrawn. Upon IL-3 withdrawal, it was observed that calcium moves from the ER into the mitochondria, elevating mitochondrial calcium and decreasing ER calcium. Bcl-2 overexpression blocked this movement of calcium and inhibited apoptosis. Notably, TG-releasable calcium before IL-3 withdrawal was the same in control cells and Bcl-2-overexpressing cells. Thus, based on this earliest study there was no suggestion that Bcl-2 decreased the calcium content of the ER. Quite the contrary, it appeared that Bcl-2 preserved ER calcium following IL-3 withdrawal. Another report in the same year concluded that Bcl-2 overexpression did not affect ionophore (ionomycin or A23187)-releasable calcium in PC12 neural cells (Zhong et al., 1993) . These reports were soon followed by a brief but interesting paper indicating that cytoplasmic calcium waves develop soon after serum withdrawal in NIH3T3 cells (Magnelli et al., 1994) . These calcium waves preceded the onset of apoptosis and were abolished by Bcl-2 overexpression. There was no indication in this report that Bcl-2 had any effect on luminal calcium.
A series of reports from the laboratory of one of the authors of this review (CWD) supports the view t hat Bcl-2 preserves, rather than depletes ER calcium. In the initial report from this laboratory, it was found that disruption of intracellular calcium homeostasis by TG induces apoptosis, and that this apoptosis, as well as the TG-induced elevation of cytoplasmic calcium concentration were inhibited by Bcl-2 overexpression (Lam et al., 1994) . Two additional calcium parameters were measured in this study. One was cytoplasmic calcium elevation induced by the calcium ionophore ionomycin. EGTA was added to cells immediately before adding ionomycin, so that the major source of calcium contributing to cytoplasmic calcium elevation was from the ER. Over a broad range of ionomycin concentrations the resulting calcium elevation was the same in control cells and in Bcl-2-overexpressing cells, suggesting that ER calcium content was unaffected by Bcl-2. The second parameter was the rate and amount of 45 Ca uptake into the ER lumen. This was not different in Bcl-2 overexpressing cells versus control cells. Together these parameters suggested that Bcl-2 did not alter calcium homeostasis within the ER lumen. In a follow-up study, the observation that Bcl-2 decreased TG-induced cytoplasmic calcium elevation was found to be dependent on the temperature at which cells were loaded with Fura-2 AM, and therefore likely was due to a temperature-dependent difference in dye distribution between Bcl-2 overexpressing cells and control cells . Also, two subsequent studies from the same laboratory demonstrated that Bcl-2 preserved the TG-releasable ER calcium pool when cells were treated with hydrogen peroxide or when extracellular calcium concentration was reduced He et al., 1997) . Finally, the low-affinity calciumsensitive dye Fura-2 FF has been used to measure free calcium concentration within the lumen of WEHI7.2 lymphoma cells and no effect of Bcl-2 on luminal calcium concentration has been detected (CWD, unpublished data).
The concept that Bcl-2 does not decrease ER luminal calcium content is further supported by published reports from a number of different laboratories. Most of these studies have used TG-releasable calcium as an indirect measure of ER luminal calcium. Four of these reports indicated that Bcl-2 had no effect on the TG-releasable calcium (Bian et al., 1997; Ichimiya et al., 1998; Wei et al., 1998; Nutt et al., 2002) , while three other reports indicated that Bcl-2 increased TG-releasable calcium (Kuo et al., 1998; Zhu et al., 1999; Williams et al., 2000) . Although most studies focused on Bcl-2, one study investigated the effect of Bcl-xL on ER luminal calcium, using a completely different strategy. Pan et al. (2000) stably expressed ryanodine receptors in CHO cells and induced calcium release from the ER by adding caffeine. Stable Bcl-xL overexpression did not alter caffeine-induced release of calcium, suggesting that the amount of calcium stored in the ER was not changed by overexpression of Bcl-xL.
Evidence that Bcl-2 decreases ER calcium
Having reviewed evidence that Bcl-2 does not decrease the TG-releasable calcium pool, we now turn attention to three recent studies that conclude just the opposite. Each of these reports indicates that Bcl-2 overexpression decreases the TG-releasable calcium pool. Furthermore, each incorporates an assay that directly measures ER luminal calcium concentration and concludes that Bcl-2 overexpression reduces free calcium concentration within the ER lumen. The first to be considered here is that of Pinton et al. (2000) . In their studies, Bcl-2 was transiently overexpresssed in HeLa cells, together with an organelle-targeted chimera of the calcium-sensitive photoprotein aequorin. Under these circumstances Bcl-2 was found to increase calcium leak from the ER, thereby reducing steady-state calcium levels in the ER. Moreover, these investigators found that Bcl-2 inhibits calcium release from the ER induced by ATP, which acts on Gq-coupled P2Y receptors to generate InsP 3 . Also, uptake of extracellular calcium in response to calcium release from the ER (capacitative calcium entry) was reduced by Bcl-2 overexpression. The second study indicating that Bcl-2 decreases ER luminal calcium is that of Foyouzi-Youssefi et al. (2000) . This study employed mouse lymphoma A20 cells and rat embryo fibroblasts, each stably overexpressing Bcl-2. Also, Bcl-2 was transiently overexpressed in HEK293. It was found that Bcl-2 decreases the amount of calcium released from the ER both by TG and also by ionomycin. ER-targeted calcium-sensitive fluorescent cameleon proteins were used to measure the free calcium concentration in the ER lumen, with results indicating that Bcl-2 overexpression decreases luminal calcium concentration. Moreover, by measuring the kinetics of calcium release induced by TG, these investigators conclude that Bcl-2 increases the permeability of the ER to calcium. The third study indicating that Bcl-2 decreases ER luminal calcium is that of Vanden Abeele et al. (2002) . Their studies were performed in LNCaP prostate cancer cells that stably overexpress Bcl-2. Their findings also indicated that Bcl-2 inhibits TG-releasable calcium. Moreover, they employed the low-affinity calcium-sensitive dye Mag-Fura-2 to measure free calcium concentration in the ER lumen, and also concluded that Bcl-2 decreases free luminal calcium concentration.
Why the controversy?
In all, 14 reports conclude that Bcl-2 does not decrease ER luminal calcium, whereas four reports conclude that Bcl-2 does decrease ER luminal calcium. If science were democratic the nays would have it and there would be no reason to look further. However, three of the reports indicating that Bcl-2 decreases luminal calcium included direct measurements of luminal calcium. However, each of these studies reported a marked decrease in TG-releasable calcium. Hence, there would still be a controversy even if the direct assays of ER calcium had not been employed. Moreover, one of us (GCS) supports the concept that Bcl-2 reduces ER calcium stores, based on stable targeting of Bcl-2b5 to the ER in H1299 lung carcinoma cells (Breckenridge et al., 2003b; unpublished) . Thus, whether or not direct assays are used does not explain the discrepancy in findings among investigators. Another variable among different studies is the use of stable versus transient overexpression of Bcl-2. The toxicity of transient Bcl-2 overexpression is well documented (Uhlmann et al., 1998; Wang et al., 2001) . One might argue, therefore, that evidence based on transient overexpression of Bcl-2 may be secondary to effects of decreased cell viability on calcium homeostasis. However, this does not fully account for the controversy since stable overexpression of Bcl-2 was employed in three of the four studies reporting that Bcl-2 decreases ER luminal calcium.
It is likely that conflicting findings regarding the effect of Bcl-2 on ER luminal calcium have arisen due to the failure of most studies to take into account the full complexity of calcium homeostasis. A number of proteins contribute to regulation of intracellular calcium and are therefore considered to be components of 'a calcium signaling toolkit' (Berridge et al., 2000 (Berridge et al., , 2003 Bootman et al., 2001) . A number of proteins influence ER luminal calcium concentration, including SERCA pumps and luminal calcium binding proteins such as calreticulin, GRP78 and GRP94. Of all the published studies that have measured the effect of Bcl-2 on luminal calcium, only two have controlled for the levels of one or both of these sets of proteins. Kuo et al. (1998) reported that Bcl-2 overexpression in MCF710a cells was associated with increased TG-releasable calcium and attributed this to elevated expression of SERCA2 pumps. Vanden Abeele et al. (2002) reported that Bcl-2 overexpression is associated with decreased ER luminal calcium and attributed this decrease to downregulation of both SERCA2b and calreticulin. Interestingly, it has been reported that Bcl-xL overexpression is associated with a decrease in InsP 3 -mediated calcium release from the ER due to markedly reduced expression of InsP 3 receptors (Li et al., 2002) , although in another report InsP 3 receptor expression was not reduced when assessed in cells overexpressing Bcl-2 (Kuo et al., 1998) . Collectively, the findings of these studies are particularly significant because they indicate that Bcl-2-associated changes in ER luminal calcium or release of calcium from the ER are not necessarily due to a direct effect of Bcl-2 on calcium homeostasis, but due to secondary changes in expression of one or more proteins in the calcium signaling toolkit.
A fundamental weakness of all published studies regarding the effect of Bcl-2 on ER calcium is that they have employed Bcl-2 overexpression, rather than investigating effects of endogenously expressed Bcl-2 on calcium. As noted above, overexpression of wild-type Bcl-2 can be quite toxic to cells, and even induce apoptosis (Uhlmann et al., 1998; Wang et al., 2001) . It is possible, therefore, that cells surviving Bcl-2 overexpression may have altered expression of one or more proteins. A number of ER luminal calcium binding proteins (e.g., calreticulin, GRP78, GRP94) are stress proteins. Therefore, it is not surprising that their expression may be altered following Bcl-2 overexpression. Furthermore, altered expression of these proteins can affect not only calcium homeostasis in the ER, but also sensitivity to apoptosis. For example, increased expression of GRP78 and calreticulin has been shown to inhibit oxidative stress, release of calcium from the ER, and cell death (Liu et al., 1997; Yu et al., 1999) . Moreover, increased expression of calreticulin increases ER luminal calcium and deceases store-operated calcium influx (Mery et al., 1996) . Finally, it is curious that Bcl-2 overexpression should be associated with an alteration in expression of proteins that affect calcium homeostasis. Future studies will be required to determine if altered expression of one or more members of the calcium toolkit is in response to some specific action of Bcl-2 or is just by chance. The next step: targeted expression of Bcl-2 family proteins at the ER or mitochondria Additional challenges arise from the recognition that cellular calcium homeostasis as well as calcium signaling is influenced by a complex relationship between the ER and the mitochondrion (see Breckenridge et al., 2003a; Hajnoczky et al., 2003) . All antiapoptotic BCL-2 members, as well as BAX/BAK and certain of the BH-3 only proteins, contain a tripartite targeting sequence at the extreme COOH-terminus of the protein, comprised of a hydrophobic transmembrane segment flanked on either side by hydrophilic stretches containing a varying number of basic amino acids. It is these flanking regions as well as the length and hydrophobicity of the hydrophobic segment that determines the cellular distribution of these proteins and their predominant locations at the ER or mitochondrial outer membrane (MOM) (see Germain and Shore, 2003) . Moreover, recent studies suggest an unexpected degree of selectivity among Bcl-2 family proteins for one membrane over the other. For example, a detailed analysis by Kaufmann et al. (2003) of the molecular architecture of the targeting sequences of Bcl-2 and Bcl-X L has revealed that Bcl-X L may exhibit a default selection of the OMM while BCL-2 distributes to both the ER and MOM and perhaps to other membranes. Also, because of the potential for overlap between the signals that direct insertion into either ER or MOM, the location of newly synthesized proteins may be further influenced by the action of other factors. Consistent with this, for example, is the finding that mitochondrial FKBP38 interacts with and influences the distribution of Bcl-2/ Bcl-X L , effecting their concentration at this site. When endogenous FKBP38 was knocked down by RNA interference (RNAi), most newly synthesized Bcl-2 molecules now distributed along their default pathway to the ER/nuclear envelope compartment (Shirane and Nakayama, 2003) .
Although proapoptotic Bax and Bak concentrate at the MOM, a measurable and consistent fraction also distributes to the ER (reviewed in Breckenridge et al., 2003a; Oakes et al., 2003) . And among BH3-only members with a C-terminal membrane anchor, human Bik concentrates almost exclusively at the ER Mathai et al., 2002) . These observations, coupled with the findings from cells derived from the Bax,Bak double gene-deleted mouse that ectopic ERrestricted Bak influences calcium homeostasis Zhong et al., 2003) , strongly implying a role for the proapoptotic versus antiapoptotic Bcl-2 multidomain family setpoint at the ER, and its regulation by a BH3-only member (Thomenius et al., 2003) . In view of the cooperation between ER and mitochondria in regulating calcium homeostasis and the differential distribution of Bcl-2 family members between these two organelles, future work must include cell types in which both the total complement of endogenous Bcl-2 members and their distribution have been catalogued. Moreover, strategies are in place for selected targeting of Bcl-2 members to either the ER or mitochondria, and this can be exploited to study effects of site-specific members on ER calcium. Of particular interest in this regard is the ratio of antiapoptotic Bcl-2 members versus proapoptotic Bax,Bak. ER luminal calcium appears to be lower in mouse embryo fibroblasts derived from Bax,Bak-deleted animals compared to wt, and it has been reported that wt cells harbor constitutive amounts of Bak at the ER (about 15% of total) . In other cell types, on the other hand, constitutive levels of Bax,Bak at the ER are undetectable and the appearance of Bak or Bax at the ER appears to depend on stress signals (unpublished). Thus even in the resting state, the ratio of anti-versus proapoptotics might vary between cells types and conceivably influence ER calcium stores.
While the anti-/proapoptotic Bcl-2 setpoint at the ER is one candidate for regulating ER calcium during apoptosis, other candidates also exist, as alluded to earlier. Obviously, the question of Bcl-2's role in regulating ER calcium homeostasis will greatly benefit from an understanding of the underlying operating mechanisms of these proteins at the ER, and this will likely emerge only when their binding partners have been elucidated and validated. The accompanying Figure 1 identifies some of the candidate Bcl-2-interacting proteins at the ER for which there is evidence for their involvement in calcium signaling.
Summary and conclusion
There are conflicting findings as to whether or not Bcl-2 overexpression decreases ER luminal calcium. Based on recent reviews of this topic, it appears that this controversey is underappreciated and a number of investigators conclude that Bcl-2 decreases ER luminal calcium without recognizing abundant evidence to the contrary. Inconsistency in findings among published studies is likely due to failure to control for changes in expression of an array of proteins that influence calcium homeostasis, including luminal calcium binding proteins such as calreticulin. Also, all studies published to date have employed Bcl-2 overexpression rather than studying endogenous Bcl-2. This is potentially problematic since stress-induced changes in gene expression may occur secondary to Bcl-2 overexpression. Because of the importance of calcium in signaling apoptosis, further work is needed to clarify potential effects of endogenous Bcl-2, as opposed to overexpressed Bcl-2, on apoptosis-associated calcium signals.
